ALDH1A1 and lung disorder: To explore the utility of serum ALDH1A1 as potential biomarker for lung cancer, we tested ALDH1A1 protein levels in sera from 25 NSCLC patients with early-stage disease, 20 NSCLC patients with advanced stage disease, 17 patients with nonneoplastic pulmonary diseases and 9 healthy donors.